
|Articles|March 1, 2002
Combination glaucoma agents produce good control of IOP
Cincinnati, OH-The IOP-lowering effect of dorzolamide HCl/timolol maleate (Cosopt, Merck, West Point, PA) is comparable to that of brimonidine tartrate (Alphagan, Allergan, Irvine, CA) and timolol maleate after 6 months of treatment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























